DJIA 18,030.21 6.04 0.03%
NASDAQ 4,773.47 8.05 0.17%
S&P 500 2,081.88 -0.29 -0.01%
market minute promo

6.99 -0.03 (-0.43%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PGNX $6.99 -0.43%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.01
Previous Close $7.02
Daily Range $6.95 - $7.20
52-Week Range $3.10 - $7.57
Market Cap $486.2M
P/E Ratio 63.82
Dividend (Yield) $0.00 (0.0%)
Volume 438,969
Average Daily Volume 1,360,236
Current FY EPS $0.02

Sector

Healthcare

Industry

Drugs

Progenics Pharmaceuticals, Inc. (PGNX) Description

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Website: http://www.progenics.com/

News & Commentary Rss Feed

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

The Biggest Risks For Stocks In 2015?

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Tiger Management's Julian Robertson Buys Alibaba, eBay, MasTec, Sells Tableau Software, ...

Progenics Pharmaceutical (PGNX) Upgraded From Sell to Hold

Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street

Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street

Progenics Pharmaceuticals' (PGNX) CEO Mark Baker Q3 2014 Results - Earnings Call Transcript

Morning Market Movers

Looking For My Next Triple In Biotech

Phase 2 Data for Progenics' 1404 Imaging Agent Presented at EANM Congress

See More PGNX News...

PGNX's Top Competitors

PGNX $6.99 (-0.43%)
Current stock: PGNX
AMGN $160.67 (2.00%)
Current stock: AMGN
GILD $91.15 (1.90%)
Current stock: GILD
BIIB $340.89 (1.53%)
Current stock: BIIB